Bevicra 100 mg Injection
$203,98
$121,38
Bevicra 100 mg injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon, non-small cell lung, glioblastoma, kidney, and ovarian cancers. This medication contains Bevacizumab, a monoclonal antibody that effectively inhibits vascular endothelial growth factor (VEGF), a protein that plays a crucial role in tumor growth and blood vessel formation. By blocking VEGF, Bevicra helps to limit the blood supply to tumors, thereby stunting their growth and progression. It is often used in combination with other cancer treatments to enhance efficacy and improve patient outcomes. As with any medication, Bevicra may carry certain risks, including potential side effects such as hypertension or increased risk of bleeding, necessitating careful monitoring by healthcare professionals. It is important to discuss your medical history and any ongoing treatments with your doctor before starting Bevicra. This medication is a vital option for those seeking to manage aggressive cancer types and improve their quality of life.
數量
Active Pharmaceutical Ingredient
Uses
• Bevicra 100 mg injection is utilized in the treatment of colorectal cancer, which affects the colon or rectum. Patients may experience symptoms such as changes in bowel habits, abdominal pain, and unintended weight loss. By targeting cancerous cells, Bevicra helps manage the disease and alleviate symptoms. This medication is often part of a comprehensive treatment plan for individuals diagnosed with this type of cancer.
• Bevicra 100 mg injection is effective for patients with non-small cell lung cancer, a common type of lung cancer. Symptoms may include persistent coughing, chest discomfort, and fatigue. The injection works by targeting the cancer cells, which can help improve the patient's quality of life. It is typically administered as part of a broader approach to lung cancer management.
• In the treatment of glioblastoma, Bevicra 100 mg injection plays a crucial role in addressing this aggressive form of brain cancer. Patients may present with symptoms such as headaches, nausea, and cognitive changes. Bevicra helps to inhibit tumor growth, providing a therapeutic option for managing this challenging condition. It is often used in conjunction with other treatments to optimize patient outcomes.
• Bevicra 100 mg injection is also indicated for kidney cancer, which develops in the kidney's lining cells. Symptoms can include blood in the urine, back pain, and swelling in the legs. This medication aids in targeting the cancerous cells, potentially improving overall prognosis. It is commonly integrated into a treatment regimen tailored for kidney cancer patients.
Benefits
Bevacizumab Injection 100 mg can help to slow or stop the growth of cancer cells, which may lead to a reduction in the size of tumors or the spread of cancer to other parts of the body. Bevicra 100 mg Injection may help to reduce the risk of cancer progressing, which may improve the chances of successful long-term treatment outcomes. In some studies, Bevicra 100 mg has been shown to improve survival rates in people with certain types of cancer, including colorectal, ovarian, and lung cancer.
Side Effects
Like all medications, Bevicra 100 mg Vial can cause side effects, but they do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Body Weakness
• Constipation
• Loss of Appetite
• Speech Change
• Nausea
• Diarrhoea
Common Side Effects
• Allergic Reactions
• Delay in Wound Healing
• Change in Vision
• Headache
• High Blood Pressure
How To Use
Bevicra 100 mg Vial is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Bevicra 100 mg will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this Bevicra 100 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Anti-cancer Drug Bevicra. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Bevacizumab Injection 100 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Bevicra Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Bevicra Injection. Bevicra 100 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Bevicra Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Bevicra 100 mg if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Bevicra 100 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bevicra Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Bevicra 100 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Bevicra Injection.